Medicaid funding cuts from the One Big Beautiful Bill Act jeopardize rural hospitals in Washington by increasing uncompensated care and risking closures, threatening access to essential healthcare services for 350,000 Medicaid enrollees.

The Joint Economic Committee critiques COVID-era enhanced premium tax credits for driving up healthcare costs without improving health outcomes, urging a reevaluation of subsidy policies to promote cost reduction and healthier populations.

CMS sets 2027 maximum fair prices for 15 high-cost Medicare drugs, cutting costs by up to 85% and saving $12 billion annually under Inflation Reduction Act measures.

Congresswoman Jen Kiggans calls for eliminating Obamacare amid federal spending cuts debate, facing criticism over Medicaid cuts and healthcare access in rural areas.

The Increasing Medication Access for Seniors Act of 2025 proposes interest-free monthly payments for costly Medicare prescriptions, improving affordability and transparency in the Medicare Prescription Payment Plan.

UCLA Luskin research investigates healthcare market consolidation effects and public option insurance's role in reducing costs and improving affordability in the U.S. health sector.

CMS proposes to cancel the rule requiring Medicare Advantage plans to notify beneficiaries of unused supplemental benefits amid low utilization and administrative challenges.

Medicare open enrollment runs through Dec. 7, 2025. Learn about key 2026 changes in Medicare Advantage and Part D plans, prescription drug costs, premium adjustments, and cost-saving programs.

House Republicans face criticism for lack of action on ACA tax credit expiration, which threatens to increase healthcare costs for millions. No clear extension plan in sight amid upcoming deadlines.

Overview of US Congressional healthcare legislation, FDA's AI modernization, CMS payment reforms, and key trade agreements influencing the insurance landscape in 2025.